baber/WOPTO huggingface dataset:
Patent EP-0809643-B1 (EP)
Inventor: HUDLICKY TOMAS
IPC: C07D491/056
Filed: 1996-02-14
Granted: 2001-10-17
Abstract: This is described an improved process for the asymetric synthesis of (+)-Pancratistatin utilizing aziridines as the starting materials.
Patent EP-0814746-B1 (EP)
Title: Concept de gilet ameliore pour systeme de reanimation cardio-pulmonaire
Inventor: GELFAND MARK
IPC: A61H31/00
Filed: 1996-03-15
Granted: 2008-07-16
Abstract: Cette invention concerne un concept de gilet amélioré (10) destiné à la réanimation cardio-pulmonaire, lequel gilet (10) comprend une vessie gonflable (22) pouvant se dilater radialement de manière à s'adapter, dans un premier temps, aux dimensions de la poitrine du patient, puis à exercer une pression circonférentielle. Ce concept de gilet amélioré (10) permet de faciliter sa mise en place sur le patient, indépendamment de la façon dont le gilet (10) a été serré au départ. Cette invention concerne également divers concepts de gilets (88, 90, 92) permettant de réduire la quantité d'air comprimé utilisée durant chaque cycle de compression ou de décompression du gilet (10). Ces améliorations permettent de réduire la consommation d'énergie et de fabriquer des systèmes de réanimation cardio-pulmonaire portables et de taille réduite.
Patent EP-0847376-B1 (EP)
Inventor: PUGH SYDNEY M
IPC: A61F2/00
Filed: 1996-08-30
Granted: 2005-02-23
Abstract: The present invention is directed to a synthetic biomaterial compound based on stabilized calcium phosphates and more particularly to the molecular, structural and physical characterization of this compound. The compound comprises calcium, oxygen and phosphorous, wherein at least one of the elements is substituted with an element having an ionic radius of approximately 0.1 to 1.1 Å. The knowledge of the specific molecular and chemical properties of the compound allows for the development of several uses of the compound in various bone-related clinical conditions.
Patent EP-0876702-B1 (EP)
Inventor: NICHOLS STEPHEN B
IPC: H02K17/30
Filed: 1996-10-18
Granted: 2006-02-22
Abstract: Un moteur rotatif et un palier magnétique rotatif sont intégrés pour former une unité compacte (10), fonctionnant sans contact. Un stator (16) entoure un rotor ferromagnétique (18) avec un espace d'air annulaire (20) qui peut recevoir une paroi cylindrique (12e), par exemple une chambre, pour le traitement de tranches de semi-conducteur. Le stator (16) a un ou des aimants permanents (38) en sandwich entre des plaques magnétiques (36) de stator espacées verticalement, avec une pluralité de segments polaires (36a). Le rotor (27) est, de préférence, un anneau en acier inoxydable magnétique avec des dents polaires complémentaires (18c). Le stator (16) subit une lévitation et centre passivement le rotor le long d'un axe vertical, empêche son inclinaison par rapport à l'un ou l'autre axe horizontal (26, 28), donne au rotor (22) une polarisation en position radiale et fournit du champ de flux moteur aux pôles du rotor. Des enroulements polyphasés (40) enroulés autour des plaques (36) du stator, produisent un champ à flux tournant qui entraîne le rotor (22) à la manière d'un moteur homopolaire synchrone. Un rotor (22) sans dents polaires permet un fonctionnement avec un entraînement inductif asynchrone. Un dispositif de commande (54) alimente les enroulements de commande (42) enroulés sur chaque segment (36a) polaire de stator, en réponse à une position spatiale détectée du rotor (22). Les enroulements de commande (42) assurent une commande active de la position radiale et permettent d'amortir activement les oscillations longitudinales et transversales qui pourraient empêcher le centrage passif.
Patent EP-0867966-B1 (EP)
Inventor: KUNZ PASCAL
IPC: H01Q1/52
Filed: 1997-03-24
Granted: 2003-07-09
Abstract: The integrated circuit structure (1) is formed in a substrate (2). The integrated circuit (1) has at least one integrated circuit element (3,4). It also has an antenna coil (5) to emit or receive information. At least one integrated circuit element (3,4) is associated with the antenna coil (5). A metal protective ring (20) is located on the periphery of the integrated circuit structure (1). The protective ring (20) has at least one Ohmic interruption such that it does not form a closed circuit by itself. This thus renders the functioning of the antenna coil (5) insensitive to the presence of the protective ring (20).
Patent EP-0819758-B1 (EP)
Inventor: MIXSON ARCHIBALD JAMES
IPC: A61P35/00
Filed: 1997-07-16
Granted: 2006-09-20
Abstract: Cationic vehicles:DNA complexes comprising DNA encoding anti-angiogenic peptide or DNA encoding a tumor suppressor protein and DNA encoding an anti-angiogenic peptide, as well as their use in gene therapy, are disclosed. <IMAGE>
Patent EP-0818144-B1 (EP)
Inventor: ZEUN RONALD
IPC: A01N37/34
Filed: 1994-06-20
Granted: 2000-08-30
Abstract: Plant microbicide composition comprises at least 2 active components in a ratio providing a synergistic fungicidal activity. The composition comprises a first component (I) selected from fludioxonil (i.e. 4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1H-pyrrole-3-carbonitrile) (Ia) and a 4-(dihalophenyl)-1H-pyrrole-3-carbonitrile of formula (Ib); and a component (II) comprising 2-phenylamino-4-cyclopropyl-6-methyl-pyrimidine. R1 = F or Cl; R2 = Cl or CF3.
Patent EP-0911476-B1 (EP)
Inventor: TOMASO PICCIONI
IPC: E06B9/60
Filed: 1997-10-21
Granted: 2002-09-04
Abstract: A frame comprises a first roller shutter box (1) housing a take-up roller (2), and a second roller shutter box (3) wherein a shaft (4) turns; a first elastic mechanism (5) rotates the take-up roller (2), while a second elastic mechanism (6) rotates the shaft (4); the take-up roller (2) stretches a blind (7) which is drawn between the take-up roller (2) and a manoeuvring bar (8) sliding on two guides (9,10); two pulleys (11,12) are splined to the ends of the shaft (4) for manoeuvring two tie rods (13,14) connected to the manoeuvring bar (8); the tie rods (13,14) are located inside the respective guides (9,10) for transmitting the tensile stress of the second elastic mechanism (6) to the manoeuvring bar (8); this stress prevails on the stress of the first elastic mechanism (5), therefore the blind (7) closes the French window when only the stresses of both elastic mechanisms (5,6) are applied to the blind (7). <IMAGE>
Patent EP-0795779-B1 (EP)
Inventor: ALSCHER EDBERT
IPC: G03B1/48
Filed: 1997-02-27
Granted: 2003-08-13
Abstract: The camera has an objective and an image window (7) in the path of the film. The film is moved intermittently past the window by a transport mechanism and an aperture between the objective and window is opened when the film is stationary. An additional aperture is mounted in the light path behind the objective. The aperture (8) is guided by a device (70-75) connected to the image window and fully covers the window when in the closed state. The aperture moves essentially perpendicular to the film transport direction.
Patent EP-0886778-B1 (EP)
Inventor: PFEIFER MARTIN
IPC: G01N33/52
Filed: 1997-01-24
Granted: 2001-06-20
Abstract: PCT No. PCT/EP97/00337 Sec. 371 Date Jul. 24, 1998 Sec. 102(e) Date Jul. 24, 1998 PCT Filed Jan. 24, 1997 PCT Pub. No. WO97/27482 PCT Pub. Date Jul. 31, 1997The present invention provides methods and compositions relating to synthetic test stains comprising isolated fibrin and/or fibrin precursors and blood plasma proteins. Kits for the preparation of synthetic test stains containing an isolated fibrin precursor and an initiator for converting the fibrin precursor to fibrin are also provided. In addition, methods for checking the efficiency of cleaning processes, and kits for carrying out these methods are provided.
Patent EP-1008432-B1 (EP)
Inventor: NOMURA MANABU
IPC: B29C45/26
Filed: 1997-02-13
Granted: 2006-05-10
Abstract: PCT No. PCT/JP97/00371 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 13, 1997 PCT Pub. No. WO97/29896 PCT Pub. Date Aug. 21, 1997The method of forming a light-weight, fiber-reinforced, particularly glass fiber-reinforced-thermoplastic resin product includes the steps of melting and mixing thermoplastic resin pellets containing parallely oriented fibers 2-100 mm long, injecting the melted resin into a cavity which is closed so that its volume is smaller than that of the final molded product, and, before or after the resin injection is completed, opening the cavity until its volume is equal to that of the final molded product. Unlike the conventional injection-molded products, this product does not require a foaming agent and, if it uses any, requires only a small amount of foaming agent. The product thus formed is light in weight and has fibers uniformly entangled inside, providing an excellent appearance of the surface. Further a skin layer is formed over the surface. These features combined with the reinforcement by the glass fibers offer high strength and high stiffness.
Patent EP-0876511-B1 (EP)
Inventor: GORDON JULIAN
IPC: C12Q1/68
Filed: 1997-01-22
Granted: 2002-12-04
Abstract: Provided herein is a method for analyzing a target nucleic acid to determine the number of tandemly repeated sequences, which may form a part of the target sequence, relative to a complementary oligonucleotide. Also provided is a target sequence capture reagent for capturing a target sequence which comprises a tandemly repeated sequence.
Patent EP-0879316-B1 (EP)
Inventor: MARCHAND RENE
IPC: D03D15/00
Filed: 1997-01-31
Granted: 2000-08-09
Abstract: A papermaker's fabric for use in the press section of a papermaking machine having a base fabric layer woven from either oval shaped monofilament yarns or "cabled monofilament oval yarns", which are cabled yarns comprised of two or more oval shaped monofilament yarns.
Patent EP-0886515-B1 (EP)
Inventor: BRETON LIONEL
IPC: A61K8/00
Filed: 1997-03-05
Granted: 2002-01-16
Abstract: Methods and compositions for induction or stimulation of hair growth and retardation of hair loss are provided. Preferably, these compounds will include a perhalogenated alkyl radical having 1 to 4 carbon atoms.
Patent EP-1028924-B1 (EP)
Inventor: ESPINOSA BRUNO
IPC: C04B7/32
Filed: 1997-11-06
Granted: 2003-04-02
Abstract: The invention concerns a method for making alumina cement wherein the concentration d3 in alumina Al2O3, -A-, and the concentration d4 in lime CaO, -C-, in the initial mixture are such that d3/d4 ranges between 1.15 and 1.40, and grinding produces a cement with size distribution as represented in a Rosin Rammler diagram has a gradient ranging between 0.75 and 0.90. The invention also concerns a plant for making alumina cement and the resulting alumina cement.
Patent EP-0895530-B1 (EP)
Inventor: KRANIG WOLFGANG
IPC: C08F2/46
Filed: 1997-03-24
Granted: 2003-11-12
Abstract: The present invention relates to a radiation-curable binder BM consisting of a copolymer which is composed of:A) from 80 to 99% by weight of a hydroxyl-containing polyether acrylate and/or polyester acrylate A), which optionally contains a mono-, di- and/or polyamine AA) as adduct, and ofB) from 1 to 20% by weight of benzophenonetetracarboxylic acid, its anhydrides and/or its esters.The invention additionally relates to processes for the preparation of the binder BM and to the use of the binders BM in radiation-curable coating compositions.
Patent EP-0883462-B1 (EP)
Inventor: EMERTON NEIL
IPC: B23K26/08
Filed: 1997-02-25
Granted: 2005-12-21
Abstract: A laser drilling process forms a plurality of holes in a pharmaceutical dosage form (12). A high power carbon dioxide laser is steered by an acousto-optic beam deflector (16) with various mirrors (17, 18, 19) and lenses (22, 23, 33, 34, 35) to the dosage form to produce holes at rates up to 100,000 units per hour.
Patent EP-0900234-B1 (EP)
Inventor: KIM HYUN K
IPC: C07J9/00
Filed: 1997-04-30
Granted: 2000-07-05
Abstract: A compound having the general formula: in which: R1 is a member selected from the group consisting of —OCH3, —SCH3, —N(CH3)2, —NHCH3, —CHO, —COCH3 and —CHOHCH3; R2 is a member selected from the group consisting of halogen, alkyl, acyl, hydroxy, alkoxy, acyloxy, alkyl carbonate, cypionyloxy, S-alkyl and S-acyl; R3 is a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; R4 is a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of ═O and ═N—OR5, wherein R5 is a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce labor; and for contraception.
Patent EP-0901523-B1 (EP)
Inventor: BOUQUET JEAN-FRANCOIS
IPC: C12N7/01
Filed: 1997-05-22
Granted: 2007-02-21
Abstract: The invention features non-transformant immortal avian cells, in particular derived from avian tissues, i.e., other than blood or hematopoietic cells, particularly fibroblasts and epithelial cells, for instance of embryos. The avian cells are immortalized by the SV40 T+t gene in the dependence of the MTI promoter. In particular they integrate the pDAMT vector.
Patent EP-0910686-B1 (EP)
Inventor: WICKER THOMAS E
IPC: C23C16/455
Filed: 1997-06-02
Granted: 2003-01-08
Abstract: A plasma processing chamber includes a substrate holder and a dielectric member such as a dielectric window or gas distribution plate having an interior surface facing the substrate holder, the interior surface being maintained below a threshold temperature to minimize process drift during processing of substrates. The chamber can include an antenna which inductively couples RF energy through the dielectric member to energize process gas into a plasma state. The antenna can include a channel through which a temperature controlling fluid, which has been cooled by a closed circuit temperature controller, is passed. The control of the temperature of the interior surface minimizes process drift and degradation of the quality of the processed substrates during sequential batch processing of substrates such as during oxide etching of semiconductor wafers.
Patent EP-0910548-B1 (EP)
Inventor: BOGDANOVIC BORISLAV
IPC: C01B31/30
Filed: 1997-07-03
Granted: 2002-04-24
Abstract: The present invention relates to a process for the preparation of transition metal carbides from transition metal/magnesium chlorides and perchlorinated organic compounds.
Patent EP-0914321-B1 (EP)
Inventor: FARINA CARLO
IPC: B82B1/00
Filed: 1997-07-03
Granted: 2004-09-22
Abstract: A compound of formula (I): or a salt thereof, or a solvate thereof, wherein Ra represents a group R<SUB>5 </SUB>which is hydrogen, alkyl or optionally substituted aryl and Rb represents a moiety of formula (a): wherein X represents a hydroxy or an alkoxy group wherein the alkyl group may be substitued or unsubstituted or X represents a group NR<SUB>s</SUB>R<SUB>t </SUB>wherein R<SUB>s </SUB>and R<SUB>t </SUB>each independently represent hydrogen, alkyl, substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, optionally substituted arylalkyl, an optionally substituted heterocyclic group or an optionally substituted heterocyclylalkyl group, or R<SUB>s </SUB>and R<SUB>t </SUB>together with the nitrogen to which they are attached form a heterocyclic group; R<SUB>1 </SUB>represents an alkyl or a substituted or unsubstituted aryl group; and R<SUB>2</SUB>, R<SUB>3 </SUB>and R<SUB>4 </SUB>each independently represent hydrogen, alkyl, aryl or substituted aryl; R<SUB>6 </SUB>and R<SUB>7 </SUB>each independently represent hydrogen, hydroxy, amino, alkoxy, optionally substituted aryloxy, optionally substituted benzyloxy, alkylamino, dialkylamino, halo, trifluoromethyl, trifluoromethoxy, nitro, alkyl, carboxy, carbalkoxy, carbamoyl, alkylcarbamoyl, or R<SUB>6 </SUB>and R<SUB>7 </SUB>together represent methylenedioxy, carbonyldioxy or carbonyldiamino; and R<SUB>8 </SUB>represents hydrogen, hydroxy, alkynoyl, alkyl, aminoalkyl, hydroxyalkyl, carboxyalky, carbalkoxyalkyl, carbamoyl or aminosulphonyl; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
Patent EP-0915730-B1 (EP)
Inventor: BILSKI GERARD WALTER
IPC: B01D39/04
Filed: 1997-08-01
Granted: 2000-10-11
Abstract: An oil filter (10) includes a colloidal suspension (12) of PTFE particles less than 2 microns in size retained by capillary forces within the intricacies of the filter media (26) until the filter (10) is installed and engine oil flows at first engine start up following installation. The PTFE colloidal suspension (12) is completely and immediately released into the engine lubricating system when oil flow is initiated. The PTFE colloidal suspension (12) is introduced into the oil filter (10) as one of the last manufacturing steps. Oil filter (10) is disposed vertically with its outlet port (14) at the top. A quantity of the PTFE colloidal suspension is introduced into the outlet port (14) to initially fill a portion of the volume defined by a centertube (18) and a retainer (16). The PTFE colloidal suspension passes through openings (20,24) into contact with filter media (26). The capillary forces acting between filter media (26) and the PTFE colloidal suspension (12) cause the colloidal suspension (12) to be drawn in and retained within the intricacies of the filter media (26) fibers.
Patent EP-0940401-B1 (EP)
Inventor: NAKAZATO ATSURO
IPC: C07D417/06
Filed: 1997-09-19
Granted: 2002-11-06
Abstract: This invention provides a 2-carbonylthiazole derivative represented by formula (I): <CHEM> Äwherein each of Ar<1> and Ar<2> represents a phenyl group, a phenyl group having one or two substituents selected from "a halogen atom, an alkyl group having 1 to 5 carbon atoms, a trifluoromethyl group, an alkoxy group having 1 to 5 carbon atoms and a hydroxyl group" or a thienyl group; R<1> represents an alkoxy group having 1 to 5 carbon atoms, a hydroxyl group or an amino group represented by formula N(R<3>)R<4> (wherein each of R<3> and R<4> represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, or R<3> and R<4>, together with the nitrogen atom to which they are bound, form a pyrrolidino, piperidino, morpholino or piperazino group, or a pyrrolidino, piperidino, morpholino or piperazino group having one to four substituents selected from "an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms and a hydroxyl group"); Y<1>-Y<2> represents CH-CO or C=C(R<2>) (wherein R<2> represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms); and n is an integer of from 1 to 4Ü or a pharmaceutically acceptable salt thereof. It also provides a medicament which comprises the 2-carbonylthiazole derivative of formula (I) or a pharmaceutically acceptable salt thereof and a dopamine D4 receptor antagonist which contains the same as the active ingredient, which are useful as drugs for preventing and treating dopamine D4 receptor-related morbid states such as schizophrenia and problematic behavior caused by cerebrovascular accidents and senile dementia, and also as the drugs which do not induce extrapyramidal disorders as side effects.
Patent EP-0939949-B1 (EP)
Inventor: TELFORD PAUL JAMES
IPC: G09F19/22
Filed: 1997-09-22
Granted: 2003-06-04
Abstract: A sign (1) contains a plurality of self-powered light-emitting elements (5) (e.g. of tritium) which are juxtaposed to form the shape of at least one symbol (e.g. an arrow) and are contained within a housing that is adapted to be floor-mounted or mounted in a wall or the like at low-level. The elements (5) are mounted in base (2) which is sealed to a transparent lid (3) in a gas-tight manner. The base (2) and lid (3) are in turn mounted in an outer box (10) which is secured to a floor (17) to contain the sign (1) therein, substantially flush with the surface of the floor (17). The sign (1) may be used with advantage as an emergency sign or direction system at floor or low level, and does not require an electricity supply. Also disclosed is a lighting system comprising elements (5) mounted within a tube which is in turn engaged within an aluminium profile provided along its length with a recess through which the elements are visible (Figures 3 to 5).
Patent EP-0948265-B1 (EP)
Inventor: KARPPANEN HEIKKI OLAVI
IPC: A23L27/00
Filed: 1997-12-17
Granted: 2003-04-23
Abstract: Cette invention concerne un procédé de préparation d'assaisonnement alimentaire, d'ingrédients alimentaires et d'aliments, lequel consiste à incorporer des stérols et/ou des stanols d'origine végétale avec une quantité accrue d'un ou de plusieurs minéraux appartenant au groupe magnésium, calcium et potassium. L'ingestion d'aliments contenant cette combinaison permet de réduire sensiblement le taux de cholestérol ainsi que la pression sanguine. Cette diminution est plus importante que celle à laquelle on s'attend lorsque l'on cumule les effets de stérols d'origine végétale et de minéraux. Cette invention concerne également des assaisonnements alimentaires qui sont utilisés dans la préparation d'aliments ayant ces caractéristiques.
Patent EP-0941531-B1 (EP)
Inventor: BUENGER CLAUS MICHAEL
IPC: G08B13/24
Filed: 1997-11-25
Granted: 2003-04-02
Abstract: L'invention concerne un système antivol s'utilisant notamment pour protéger contre le vol des marchandises telles que des textiles ou similaire. Dans le déclencheur d'alarme décrit, comme par exemple un transpondeur, un circuit d'antennes multinappes est monté sur des couches porteuses et est relié avec un condensateur au niveau de ses points terminaux. Ce circuit d'antennes se présente donc sous la forme d'un bobinage tridimensionnel. Cette configuration facilite la détection d'un déclencheur d'alarme même dans un angle peu favorable par rapport au détecteur et augmente la distance à laquelle le déclencheur d'alarme est encore détectable.
Patent EP-0961654-B1 (EP)
Inventor: EICHENLAUB UDO
IPC: B01L3/02
Filed: 1998-02-23
Granted: 2002-12-04
Abstract: A system for producing multiple diagnostic test elements has a support (1) with an analytical region (3) to which diagnostic test spots (8) are applied, one or several stop edges (11-13) for each direction in space for positioning the support, a first holding unit (10I) into which the support is inserted and positioned by means of the one or more stop edges, a first printing head (20I) arranged above the holding unit (10) for applying drops of a first liquid to the analytical region of the support (1), a first positioning unit which laterally displaces and positions the first holding unit, a second holding unit (10II) into which the support is inserted and positioned by means of the one or more stop edges, a second printing head (20II) arranged above the second holding unit for applying drops of a second liquid to the analytical region of the support (1), a second positioning unit which laterally displaces and positions the second holding unit, a transport unit (41) and a control unit.